Table 2.

Comparison of group that underwent total PTX with subcutaneous forearm AT and group that underwent total PTX with subcutaneous intramuscular forearm AT.

	Intramuscular group	Subcutaneous group	p value
	n = 16	n = 22
Male	6 (37.5)	8 (36.4)	0.105
Age (year)	51 ± 14	60 ± 12	0.275
Dialysis vintage (months)	89 ± 37	73 ± 47	0.386
Pre-iPTH (pg/ml)	1750 ± 619	1527 ± 451	0.079
Post-iPTH (pg/ml)	63 ± 78	53 ± 66	0.831
<10	3 (18.8)	5 (22.7)	0.767
10–70	11 (68.8)	15 (68.2)	0.970
>70	2 (12.2)	2 (9.1)	0.919
6 months iPTH (pg/ml)	58 ± 66	53 ± 68	0.879
<10	0 (0.0)	1 (4.5)	0.387
10–70	15 (93.8)	20 (90.9)	0.748
>70	1 (6.3)	1 (4.5)	0.816
12 months iPTH (pg/ml)	60 ± 71	52 ± 69	0.819
24 months iPTH (pg/ml)	63 ± 77	53 ± 69	0.746
36 months iPTH (pg/ml)	64 ± 81	54 ± 74	0.756
60 months iPTH (pg/ml)	66 ± 101	57 ± 89	0.708
Follow-up time after PTX + AT (months)	106 ± 24	103 ± 18	0.710
Long-term hypoparathyroidism	0 (0.0)	1 (4.5)	0.387
Persistent hyperparathyroidism	1 (6.3)	1 (4.5)	0.816
Recurrence hyperparathyroidism	1 (6.3)	1 (4.5)	0.816
Autograftectomy	1 (6.3)	2 (9.1)	0.748

Data are show as mean ± standard deviation or number (%). Abbreviations: PTX: total parathyroidectomy; AT: autotransplantation; Pre-iPTH: preoperative intact-parathyroid hormone; Post-iPTH: postoperative intact-parathyroid hormone; 6, 12, 24, 36, and 60 months iPTH: intact-parathyroid hormone measurement at 6, 12, 24, 36, and 60 months after PTX + AT.